- Home
- ALRM vs TVTX Comparison
ALRM vs TVTX Comparison
Compare ALRM & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | TVTX |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALRM | TVTX |
|---|---|---|
| Price | $51.75 | $34.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 15 |
| Target Price | ★ $64.67 | $37.21 |
| AVG Volume (30 Days) | 428.0K | ★ 1.6M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.77 | N/A |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $991,770,000.00 | $435,826,000.00 |
| Revenue This Year | $8.53 | $120.36 |
| Revenue Next Year | $4.12 | $37.33 |
| P/E Ratio | $22.12 | ★ N/A |
| Revenue Growth | 7.36 | ★ 114.22 |
| 52 Week Low | $46.65 | $12.91 |
| 52 Week High | $69.12 | $37.50 |
Technical Indicators
Market Signals| Indicator | ALRM | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 56.76 |
| Support Level | $51.01 | $33.45 |
| Resistance Level | $52.15 | $35.64 |
| Average True Range (ATR) | 1.29 | 1.51 |
| MACD | 0.27 | -0.40 |
| Stochastic Oscillator | 65.10 | 39.01 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.